BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 23249122)

  • 1. New trends in early diagnosis of hydroxychloroquine toxic retinopathy.
    Vanderzee G; Tassi D
    Optometry; 2012 May; 83(5):200-7. PubMed ID: 23249122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
    Marmor MF; Melles RB
    Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
    Mititelu M; Wong BJ; Brenner M; Bryar PJ; Jampol LM; Fawzi AA
    JAMA Ophthalmol; 2013 Sep; 131(9):1187-97. PubMed ID: 23887202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M; Stover NB; Francis PJ; Weleber RG
    Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Report: Hydroxychloroquine Retinopathy.
    Eldeeb M; Chan EW; Omar A
    Optom Vis Sci; 2018 Jun; 95(6):545-549. PubMed ID: 29787487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.
    Browning DJ
    Am J Ophthalmol; 2013 Mar; 155(3):418-428.e1. PubMed ID: 23218706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Demise of the Bull's Eye (Screening for Hydroxychloroquine Retinopathy).
    Marmor MF
    Retina; 2016 Oct; 36(10):1803-5. PubMed ID: 27388736
    [No Abstract]   [Full Text] [Related]  

  • 8. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.
    Mavrikakis I; Sfikakis PP; Mavrikakis E; Rougas K; Nikolaou A; Kostopoulos C; Mavrikakis M
    Ophthalmology; 2003 Jul; 110(7):1321-6. PubMed ID: 12867385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxychloroquine retinopathy: an emerging problem.
    Latasiewicz M; Gourier H; Yusuf IH; Luqmani R; Sharma SM; Downes SM
    Eye (Lond); 2017 Jun; 31(6):972-976. PubMed ID: 28186509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of disease stage on progression of hydroxychloroquine retinopathy.
    Marmor MF; Hu J
    JAMA Ophthalmol; 2014 Sep; 132(9):1105-12. PubMed ID: 24922444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy.
    Melles RB; Marmor MF
    JAMA Ophthalmol; 2014 Dec; 132(12):1453-60. PubMed ID: 25275721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy.
    Rodriguez-Padilla JA; Hedges TR; Monson B; Srinivasan V; Wojtkowski M; Reichel E; Duker JS; Schuman JS; Fujimoto JG
    Arch Ophthalmol; 2007 Jun; 125(6):775-80. PubMed ID: 17562988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of the 103-hexagon multifocal electroretinogram in detection of hydroxychloroquine retinal toxicity.
    Adam MK; Covert DJ; Stepien KE; Han DP
    Br J Ophthalmol; 2012 May; 96(5):723-9. PubMed ID: 22328813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macular toxicity after short-term hydroxychloroquine therapy.
    Pasaoglu I; Onmez FE
    Indian J Ophthalmol; 2019 Feb; 67(2):289-292. PubMed ID: 30672499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of screening procedures in hydroxychloroquine toxicity.
    Marmor MF
    Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early hydroxychloroquine retinopathy: optical coherence tomography abnormalities preceding Humphrey visual field defects.
    Garrity ST; Jung JY; Zambrowski O; Pichi F; Su D; Arya M; Waheed NK; Duker JS; Chetrit Y; Miserocchi E; Giuffrè C; Kaden TR; Querques G; Souied EH; Freund KB; Sarraf D
    Br J Ophthalmol; 2019 Nov; 103(11):1600-1604. PubMed ID: 30819690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early effect of hydroxychloroquine therapy: relationship between cumulative dose and retinal thickness.
    Agarwal P; Wong YH; Dasgupta E; Agarwal R; Livingstone BI; Ramamurthy S; Chyn GS
    Cutan Ocul Toxicol; 2015; 34(3):179-84. PubMed ID: 25068998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Variability of chloroquine and hydroxychloroquine retinopathy among various ethnicities].
    Giocanti-Aurégan A; Couturier A; Girmens JF; Le Mer Y; Massamba N; Barreau E; Audo I;
    J Fr Ophtalmol; 2018 Apr; 41(4):363-367. PubMed ID: 29678344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Wolfe F; Marmor MF
    Arthritis Care Res (Hoboken); 2010 Jun; 62(6):775-84. PubMed ID: 20535788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer Therapy.
    Leung LS; Neal JW; Wakelee HA; Sequist LV; Marmor MF
    Am J Ophthalmol; 2015 Oct; 160(4):799-805.e1. PubMed ID: 26189086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.